Timber Pharmaceuticals, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported revenue was USD 0.083177 million compared to USD 0.886532 million a year ago. Net loss was USD 19.38 million compared to USD 10.64 million a year ago.

Basic loss per share from continuing operations was USD 9.19 compared to USD 13.31 a year ago.